Medical treatment of echinococcosis under the guidance of Good Clinical Practice (GCP/ICH)

Parasitology International

Volumn 55, Issue SUPPL., 2006, Pages

  Kern, Peter ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Alveolar echinococcosis; Amphotericin B; Benzimidazoles; Clinical trials; Cystic echinococcosis; Good clinical practice (GCP); Nitozoxanide; Praziquantel

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; ANTIFUNGAL AGENT; ANTIPARASITIC AGENT; BENZIMIDAZOLE DERIVATIVE; HIGH MOBILITY GROUP B1 PROTEIN; MEBENDAZOLE; PRAZIQUANTEL; TIZOXANIDE;

CHEMOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG SCREENING; FOOD AND DRUG ADMINISTRATION; GOOD CLINICAL PRACTICE; HUMAN; LIVER HYDATID CYST; LONG TERM CARE; META ANALYSIS; NONHUMAN; PIPELINE; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ANTHELMINTICS; CLINICAL PROTOCOLS; CLINICAL TRIALS; ECHINOCOCCOSIS; HUMANS; PRACTICE GUIDELINES;

EID: 31944452249     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parint.2005.11.040     Document Type: Conference Paper

References (37)

1. Guidelines for treatment of cystic and alveolar echinococcosis in humans WHO Informal Working Group on Echinococcosis Bull WHO 74 1996 231 242
2. D.D. Heath, M.J. Christie, and R.A.F. Chevis The lethal effect of mebendazole on secondary Echinococcus granulosus, cysticerci of Taenia pisiformis and tetrathyridia of Mesocestoides corti Parasitology 70 1975 273 285
3. P.M. Schantz, H. van den Bosche, and J. Eckert Chemotherapy of larval echinococcosis in animals and humans: report of a workshop Z Parasitenkd 67 1982 5 26
4. Z.S. Pawlowski, J. Eckert, D.A. Vuitton, R.W. Ammann, P. Kern, and P.S. Craig Echinococcosis in humans: clinical aspects, diagnosis and treatment J. Eckert M.A. Gemmel F.-X. Meslin Z. Pawlowski WHO/OIE Manual on Echinococcosis in Humans and Animals 2001 World Organization for Animal Health and World Health Organization Paris 20 71
5. W.C. Campbell Benzimidazoles: veterinary uses Parasitol Today 6 1990 130 133
6. D.L. Morris, P.W. Dykes, S.E. Marriner, J.A. Bogan, and F.G. Burrows Albendazole in hydatid disease Br Med J 286 1983 103 104
7. A.G. Saimot, A.C. Meulemans, M.D. Cremieux, M.D. Giovenangeli, J.M. Hay, and P. Delaitre Albendazole as a potential treatment for human hydatidosis Lancet 2 1983 652 656
8. R.J. Horton Albendazole in treatment of human cystic echinoccosis: 12 years of expericence Acta Trop 64 1997 79 93
9. E. Lacey Mode of action of benzimidazoles Parasitol Today 6 1990 112 115
10. F. Cobo, C. Yarnoz, B. Sesma, P. Fraile, M. Aizcorbe, and R. Trujillo Albendazole plus praziqantel versus albendazole alone as a pre-operative treatment in intraabdominal hydatidosis caused by Echinococcus granulosus Trop Med Int Health 3 1998 462 466
11. H. Lange, R. Eggers, and J. Bircher Increased systemic availability of albendazole when taken with a fatty meal Eur J Clin Pharmacol 34 1988 315 317
12. C.H. King, and A.A.F. Mahmoud Drugs five years later: praziquantel Ann Int Med 110 1989 290 296
13. M.A. Urrea-Paris, M.J. Moreno, N. Casado, and F. Rodriquez-Caabeiro Echinococcus granulosus: praziquantel treatment against the metacestode stage Parasitol Res 85 1999 999 1006
14. S. Reuter, M. Merkle, K. Brehm, P. Kern, and B. Manfras Effects of amphotericin B on larval growth of Echinococcus multilocularis Antimicrob Agents Chemother 47 2003 620 625
15. S. Reuter, A. Buck, O. Grebe, K. Nüssle-Kügele, P. Kern, and B. Manfras Salvage treatment with amphotericin B in the progressive human alveolar echinococcosis Antimicrob Agents Chemother 47 2003 3586 3591
16. D.P. McManus, W. Zhang, J. Li, and P.B. Bartley Echinococcosis Lancet 362 2003 1295 1304
17. A.G. Saimot Medical treatment of liver hydatidosis World J Surg 25 2001 15 20
18. P. Craig Echinococcus multilocularis Curr Opin Infect Dis 16 2003 437 444
19. C. Franchi, B. Di Vico, and Teggi Long-term evaluation of patients with hydatidosis treated with benzimidazole carbamates Clin Infect Dis 29 1999 304 309
20. L.A. Gil-Grande, F. Rodriguez-Cabeiro, J.G. Prieto, J.J. Sanches-Ruano, C. Brasa, and L. Aguilar Randomized controlled trial of efficacy of albendazole in intra-abdominal hydatid disease Lancet 342 1993 1269 1272
21. M. Keshmiri, H. Baharvahdat, S.H. Fattahi, B. Davachi, R.H. Dabiri, and H. Baradaran Albendazole versus placebo in treatment of echinococcosis Trans R Soc Trop Med Hyg 95 2001 190 194
22. M. Keshmiri, H. Baharvahdat, S.H. Fattahi, B. Davachi, R.H. Dabiri, and H. Baradan A controlled study assessing the effects of albendazole in treatment of pulmonary echinococcosis Eur Respir J 14 1999 503 507
23. R.A. Smego, S. Bhatti, A.A. Khalid, and M.A. Beg Percutaneous aspiration-injection-reaspiration drainage plus albendazole or mebendazole for hepatic cystic echinococcosis: a meta-analysis Clin Infect Dis 37 2003 1073 1083
24. C. Dziri, K. Haouet, and A. Fingerhut Treatment of hydatid cyst of the liver: where is the evidence? World J Surg 28 2004 731 736
25. D. Moher, K.F. Schulz, and D.G. Altman The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials Lancet 357 2001 1191 1194
26. K. Slim, E. Nini, D. Forestier, F. Kwiatowski, Y. Paris, and J. Chipponi Methodological index for non-randomized studies (minors): development and validation of a new instrument AUZ J Surg 73 2003 712 716
27. K. Rippmann, M. Dietrich, and P. Kern Long-term therapy of cystic liver echinococcosis with mebendazole Med Klin 87 1992 350 354
28. J.F. Rossignol, and H. Mainsoneuve Nitozoxanide in the treatment of Taenia saginata and Hymenolepis nana infections Am J Trop Med Hyg 33 1984 511 512
29. L.M. Fox, and L.D. Saravolatz Nitazoxanide: a new thiazolide antiparasitc agent Clin Infect Dis 40 2005 1273 1280
30. G. Sisson, A. Goodwin, A. Raudonikiene, N.J. Hughes, A.K. Mukhopadhyay, and D.E. Berg Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori Antimicrob Agents Chemother 46 2002 2116 2123
31. M. Walker, J.F. Rossignol, P. Torgerson, and A. Hemphill In vitro effects of nitazoxanide on Echinococcus granulosus protoscoleces and metacestodes J Antimicrob Chemother 54 2004 609 616
32. M. Stettler, R. Fink, M. Walker, B. Gottstein, T.G. Geary, and J.F. Rossignol In vitro parasiticidal effect of nitazoxanide against Echinococcus multilocularis metacestodes Antimicrob Agents Chemother 47 2003 467 474
33. M. Stettler, J.F. Rossignol, R. Fink, M. Walker, B. Gottstein, and M. Merli Secondary and primary murine alveolar echinococcosis: combined albendazole/nitazoxanide chemotherapy exhibits profound anti-parasitic activity Int J Parasitol 34 2004 615 624
34. C.D. De Angelis, J.M. Drazen, F.A. Frizelle, C. Haug, J. Hoey, and R. Horton Is this clinical trial fully registered?-A statement from the International Committee of Medical Journal Editors N Engl J Med 352 2005 2436 2438
35. World Health Organization (WHO). Puncture Aspiration Injection Re-Aspiration - An option for the treatment of cystic echinococcosis. WHO-Informal Working Group on Echinococcosis (WHO-IWGE) -;WHO/CDS/CSR/APH/2001. 6;World Health Organization, 2001.
36. R.W. Ammann, E.C. Renner, B. Gottstein, F. Grimm, J. Eckert, E.L. Renner Swiss Echinococcosis Study Group Immunosurveillance of alveolar echinococcosis by specific humoral and cellular immune tests: long-term analysis of the Swiss chemotherapy trial (1976-2001) J Hepatol 41 2004 551
37. S. Reuter, A. Buck, B. Manfras, W. Kratzer, H.M. Seitz, and K. Darge Structured treatment interruption in patients with alveolar echinococcosis Hepatology 39 2004 509 517